Runx2 regulates the expression of GNAS on SaOs-2 cells

Bone

Volumn 38, Issue 6, 2006, Pages 943-950

  Bertaux, Karine ^a   Broux, Odile ^a   Chauveau, Christophe ^a   Hardouin, Pierre ^a   Jeanfils, Joseph ^a   Devedjian, Jean Christophe ^a  

^a UNIVERSITÉ DU LITTORAL CÔTE D OPALE   (France)

Author keywords

Cbfa1 RUNX2; Differential display; GNAS; SaOs 2

Indexed keywords

ADRENERGIC RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE ALPHA BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ALBRIGHT SYNDROME; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; EVIDENCE BASED MEDICINE; FIBROUS DYSPLASIA; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MUTANT; OSTEOBLAST; OSTEOSARCOMA; PROMOTER REGION; PROTEIN FUNCTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLIC AMP; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 33749468886     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.11.025     Document Type: Article

References (27)

1. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
2. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
3. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89 (1997) 773-779
4. Barski A., and Frenkel B. ChIP Display: novel method for identification of genomic targets of transcription factors. Nucleic Acids Res. 32 (2004) e104
5. Stock M., Schafer H., Fliegauf M., and Otto F. Identification of novel genes of the bone-specific transcription factor Runx2. J. Bone Miner Res. 19 (2004) 959-972
6. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13 (1999) 1025-1036
7. Bertaux K., Broux O., Chauveau C., Jeanfils J., and Devedjian J.C. Identification of CBFA1-regulated genes on SaOs-2 cells. J. Bone Miner. Metab. 23 (2005) 114-122
8. Marie P.J. Cellular and molecular basis of fibrous dysplasia. Histol. Histopathol. 16 (2001) 981-988
9. Levine M.A. Clinical implications of genetic defects in G proteins: oncogenic mutations in G alphas as the molecular basis for the McCune-Albright syndrome. Arch. Med. Res. 30 (1999) 522-531
10. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
11. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
12. Kozasa T., Itoh H., Tsukamoto T., and Kaziro Y. Isolation and characterization of the human Gs alpha gene. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2081-2085
13. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
14. Sudhakar S., Katz M.S., and Elango N. Analysis of type-I and type-II RUNX2 protein expression in osteoblasts. Biochem. Biophys. Res. Commun. 286 (2001) 74-79
15. Lania A., Mantovani G., and Spada A. G protein mutations in endocrine diseases. Eur. J. Endocrinol. 145 (2001) 543-559
16. Albright F., Burnett C.H., Smith C.H., and Parson W. Pseudohypoparathyroidism: an example of Seabright-Bantam syndrome. Endocrinology 30 (1942) 922-932
17. Pattern J.L., Johns D.R., Valle D., Eil C., Gruppuso P.A., Steele G., et al., Levine M.A. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N. Engl. J. Med. 322 (1990) 1412-1419
18. Kaplan F.S., and Shore E.M. Progressive osseous heteroplasia. Bone Miner. Res. 15 (2000) 2084-2094
19. Shore E.M., Ahn J., Jan de Beur S., Li M., Xu M., Gardner R.J., et al. Paternally inherited inactivating mutations of the GNAS gene in progressive osseous heteroplasia. N. Engl. J. Med. 346 (2002) 99-106
20. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., and Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325 (1991) 1688-1695
21. Bianco P., Riminucci M., Majolagbe A., Kuznetsov S.A., Collins M.T., Mankani M.H., et al. Mutations of the GNAS gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J. Bone Miner. Res. 15 (2000) 120-128
22. Marie P.J., de Pollak C., Chanson P., and Lomri A. Increased proliferation of osteoblastic cells expressing the activating Gsa mutation in monostotic and polystotic fibrous dysplasia. Am. J. Pathol. 150 (1997) 1059-1069
23. Noda M., and Rodan G.A. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J. Cell Biol. 108 (1989) 713-718
24. Kream B.E., Rowe D.W., Gworek S.C., and Raisz L.G. Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 5654-5658
25. Isogai Y., Akatsu T., Ishizuya T., Yamaguchi A., Hori M., Takahashi N., et al. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J. Bone Miner. Res. 11 (1996) 1384-1393
26. Tintut Y., Parhami F., Le V., Karsenty G., and Demer L.L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells, Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 274 (1999) 28875-28879
27. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005) 514-520